Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 394

1.

Clinical Characteristics of and Risk Factors for Chronic Kidney Disease Among Adults and Children: An Analysis of the CURE-CKD Registry.

Tuttle KR, Alicic RZ, Duru OK, Jones CR, Daratha KB, Nicholas SB, McPherson SM, Neumiller JJ, Bell DS, Mangione CM, Norris KC.

JAMA Netw Open. 2019 Dec 2;2(12):e1918169. doi: 10.1001/jamanetworkopen.2019.18169.

2.

Rationale and design of a multicenter Chronic Kidney Disease (CKD) and at-risk for CKD electronic health records-based registry: CURE-CKD.

Norris KC, Duru OK, Alicic RZ, Daratha KB, Nicholas SB, McPherson SM, Bell DS, Shen JI, Jones CR, Moin T, Waterman AD, Neumiller JJ, Vargas RB, Bui AAT, Mangione CM, Tuttle KR; CURE-CKD investigators.

BMC Nephrol. 2019 Nov 20;20(1):416. doi: 10.1186/s12882-019-1558-9.

3.

Efficacy of semaglutide versus liraglutide in clinical practice.

Goncalves E, Bell DS.

Diabetes Metab. 2019 Oct 11. pii: S1262-3636(19)30155-7. doi: 10.1016/j.diabet.2019.10.001. [Epub ahead of print] No abstract available.

PMID:
31606525
4.

A study of the re-equilibration of hydrophilic interaction columns with a focus on viability for use in two-dimensional liquid chromatography.

Seidl C, Bell DS, Stoll DR.

J Chromatogr A. 2019 Oct 25;1604:460484. doi: 10.1016/j.chroma.2019.460484. Epub 2019 Aug 27.

PMID:
31488293
5.

Sustainability considerations for clinical and translational research informatics infrastructure.

Obeid JS, Tarczy-Hornoch P, Harris PA, Barnett WK, Anderson NR, Embi PJ, Hogan WR, Bell DS, McIntosh LD, Knosp B, Tachinardi U, Cimino JJ, Wehbe FH.

J Clin Transl Sci. 2018 Oct;2(5):267-275. doi: 10.1017/cts.2018.332. Epub 2018 Dec 5.

6.

Characteristics of the National Applicant Pool for Clinical Informatics Fellowships (2016-2017).

Bell DS, Baldwin K, Bell EJ 3rd, Lehmann CU, Webber EC, Mohan V, Leu MG, Hofmann JM, Kaelber DC, Landman AB, Hron J, Silverman HD, Levy B, Elkin PL, Poon E, Luberti AA, Finnell JT, Safran C, Palma JP, Forman BH, Kileen J, Arvin D, Pfeffer M.

AMIA Annu Symp Proc. 2018 Dec 5;2018:225-231. eCollection 2018.

7.

Heart failure in the patient with diabetes: Epidemiology, aetiology, prognosis, therapy and the effect of glucose-lowering medications.

Bell DSH, Goncalves E.

Diabetes Obes Metab. 2019 Jun;21(6):1277-1290. doi: 10.1111/dom.13652. Epub 2019 Mar 6. Review.

PMID:
30724013
8.

Detailed efficiency analysis of columns with a different packing quality and confirmation via total pore blocking.

Vanderlinden K, Desmet G, Bell DS, Broeckhoven K.

J Chromatogr A. 2018 Dec 21;1581-1582:55-62. doi: 10.1016/j.chroma.2018.10.052. Epub 2018 Nov 1.

PMID:
30446265
9.

Depression in Nonclassical Hypogonadism in Young Men.

Korenman SG, Grotts JF, Bell DS, Elashoff DA.

J Endocr Soc. 2018 Sep 21;2(11):1306-1313. doi: 10.1210/js.2018-00137. eCollection 2018 Nov 1.

10.

Escalating Opioid Dose Is Associated With Mortality: A Comparison of Patients With and Without Opioid Use Disorder.

Hser YI, Saxon AJ, Mooney LJ, Miotto K, Zhu Y, Yoo CK, Liang D, Huang D, Bell DS.

J Addict Med. 2019 Jan/Feb;13(1):41-46. doi: 10.1097/ADM.0000000000000458.

11.

Direct analysis of chiral active pharmaceutical ingredients and their counterions by ultra high performance liquid chromatography with macrocyclic glycopeptide-based chiral stationary phases.

Ismail OH, Antonelli M, Ciogli A, De Martino M, Catani M, Villani C, Cavazzini A, Ye M, Bell DS, Gasparrini F.

J Chromatogr A. 2018 Nov 16;1576:42-50. doi: 10.1016/j.chroma.2018.09.029. Epub 2018 Sep 17.

PMID:
30266236
12.

Atrial fibrillation and type 2 diabetes: Prevalence, etiology, pathophysiology and effect of anti-diabetic therapies.

Bell DSH, Goncalves E.

Diabetes Obes Metab. 2019 Feb;21(2):210-217. doi: 10.1111/dom.13512. Epub 2018 Sep 25. Review.

PMID:
30144274
13.

Primary care provider adherence to an alert for intensification of diabetes blood pressure medications before and after the addition of a "chart closure" hard stop.

Ramirez M, Maranon R, Fu J, Chon JS, Chen K, Mangione CM, Moreno G, Bell DS.

J Am Med Inform Assoc. 2018 Sep 1;25(9):1167-1174. doi: 10.1093/jamia/ocy073.

14.

Implementation of informatics for integrating biology and the bedside (i2b2) platform as Docker containers.

Wagholikar KB, Dessai P, Sanz J, Mendis ME, Bell DS, Murphy SN.

BMC Med Inform Decis Mak. 2018 Jul 16;18(1):66. doi: 10.1186/s12911-018-0646-2.

15.

Automating Installation of the Integrating Biology and the Bedside (i2b2) Platform.

Wagholikar KB, Mendis M, Dessai P, Sanz J, Law S, Gilson M, Sanders S, Vangala M, Bell DS, Murphy SN.

Biomed Inform Insights. 2018 Jun 4;10:1178222618777749. doi: 10.1177/1178222618777749. eCollection 2018. Review.

16.

Increase in glycated haemoglobin concentrations after unwarranted prescription changes.

Bell DSH, Goncalves E.

Diabetes Obes Metab. 2018 Oct;20(10):2510-2511. doi: 10.1111/dom.13407. Epub 2018 Jun 25. No abstract available.

PMID:
29885012
17.

Correlation between serum uric acid and diabetic peripheral neuropathy - association rather than causation.

Bell DSH.

J Neurol Sci. 2018 Jul 15;390:208. doi: 10.1016/j.jns.2018.04.025. Epub 2018 Apr 22. No abstract available.

PMID:
29801889
18.

Should we still be utilizing warfarin in the type 2 diabetic patient?

Bell DSH, Goncalves E.

Diabetes Obes Metab. 2018 Oct;20(10):2327-2329. doi: 10.1111/dom.13371. Epub 2018 Jun 13. Review.

PMID:
29790252
19.

Finally, after 56 years of type 1 diabetes: a regimen that works.

Bell DSH.

Postgrad Med. 2018 May;130(4):409-410. doi: 10.1080/00325481.2018.1472509. Epub 2018 May 14.

PMID:
29718785
20.

Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk.

Goncalves E, Bell DSH.

Diabetes Ther. 2018 Jun;9(3):919-926. doi: 10.1007/s13300-018-0420-6. Epub 2018 Apr 5. Review.

21.

RE: DIABETIC KETOACIDOSIS IN PATIENTS WITH TYPE 2 DIABETES ON SGLT-2 INHIBITORS: AN ONGOING CONCERN.

Bell DSH.

Endocr Pract. 2018 Jan;24(1):126. doi: 10.4158/1934-2403-24.1.126. No abstract available.

PMID:
29368970
22.

Improving admission medication reconciliation with pharmacists or pharmacy technicians in the emergency department: a randomised controlled trial.

Pevnick JM, Nguyen C, Jackevicius CA, Palmer KA, Shane R, Cook-Wiens G, Rogatko A, Bear M, Rosen O, Seki D, Doyle B, Desai A, Bell DS.

BMJ Qual Saf. 2018 Jul;27(7):512-520. doi: 10.1136/bmjqs-2017-006761. Epub 2017 Oct 6.

23.

Insulin Therapy Increases Cardiovascular Risk in Type 2 Diabetes.

Herman ME, O'Keefe JH, Bell DSH, Schwartz SS.

Prog Cardiovasc Dis. 2017 Nov - Dec;60(3):422-434. doi: 10.1016/j.pcad.2017.09.001. Epub 2017 Sep 25. Review.

PMID:
28958751
24.

Future perspectives in high efficient and ultrafast chiral liquid chromatography through zwitterionic teicoplanin-based 2-μm superficially porous particles.

Ismail OH, Antonelli M, Ciogli A, Villani C, Cavazzini A, Catani M, Felletti S, Bell DS, Gasparrini F.

J Chromatogr A. 2017 Oct 20;1520:91-102. doi: 10.1016/j.chroma.2017.09.008. Epub 2017 Sep 6.

PMID:
28911942
25.

Physician experiences with clinical pharmacists in primary care teams.

Moreno G, Lonowski S, Fu J, Chon JS, Whitmire N, Vasquez C, Skootsky SA, Bell DS, Maranon R, Mangione CM.

J Am Pharm Assoc (2003). 2017 Nov - Dec;57(6):686-691. doi: 10.1016/j.japh.2017.06.018. Epub 2017 Aug 12.

26.

Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus.

Bell DSH.

Ann Intern Med. 2017 Jul 4;167(1):74-75. doi: 10.7326/L17-0233. No abstract available.

PMID:
28672386
27.

Chronic pain among patients with opioid use disorder: Results from electronic health records data.

Hser YI, Mooney LJ, Saxon AJ, Miotto K, Bell DS, Huang D.

J Subst Abuse Treat. 2017 Jun;77:26-30. doi: 10.1016/j.jsat.2017.03.006. Epub 2017 Mar 9.

28.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.

Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK, Bell DSH, Mechanick JI, Pessah-Pollack R, Wyne K, Smith D, Brinton EA, Fazio S, Davidson M.

Endocr Pract. 2017 Apr;23(Suppl 2):1-87. doi: 10.4158/EP171764.APPGL.

PMID:
28437620
29.

High Mortality Among Patients With Opioid Use Disorder in a Large Healthcare System.

Hser YI, Mooney LJ, Saxon AJ, Miotto K, Bell DS, Zhu Y, Liang D, Huang D.

J Addict Med. 2017 Jul/Aug;11(4):315-319. doi: 10.1097/ADM.0000000000000312.

30.

Effects of a Laboratory Health Information Exchange Intervention on Antiretroviral Therapy Use, Viral Suppression, and Racial/Ethnic Disparities.

Cunningham WE, Ford CL, Kinsler JJ, Seiden D, Andrews L, Nakazono T, Bell DS.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):290-298. doi: 10.1097/QAI.0000000000001385.

31.

A Time and Motion Study of Pharmacists and Pharmacy Technicians Obtaining Admission Medication Histories.

Nguyen CB, Shane R, Bell DS, Cook-Wiens G, Pevnick JM.

J Hosp Med. 2017 Mar;12(3):180-183. doi: 10.12788/jhm.2702.

32.

Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors: Sequential or simultaneous start?

Goncalves E, Bell DSH.

Diabetes Obes Metab. 2017 Jun;19(6):909-911. doi: 10.1111/dom.12897. Epub 2017 Mar 8. No abstract available.

PMID:
28176440
33.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journals.aace.com.

Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK, Bell DSH, Mechanick JI, Pessah-Pollack R, Wyne K, Smith D, Brinton EA, Fazio S, Davidson M, Zangeneh F, Bush MA.

Endocr Pract. 2017 Apr 2;23(4):479-497. doi: 10.4158/EP171764.GL. Epub 2017 Feb 3.

PMID:
28156151
34.

Human Medicines Inappropriately Used in Animals Come at a Much Lower Cost.

Bell DS.

South Med J. 2017 Jan;110(1):78. doi: 10.14423/SMJ.0000000000000579. No abstract available.

PMID:
28052183
35.

Implementing Community Engagement as a Mission at the David Geffen School of Medicine at the University of California, Los Angeles.

Chung B, Brown AF, Moreno G, Cuen P, Uy V, Vangala S, Bell DS, Washington AE, Norris KC, Mangione CM.

J Health Care Poor Underserved. 2016;27(1):8-21.

PMID:
27763457
36.

Rationale behind the optimum efficiency of columns packed with new 1.9μm fully porous particles of narrow particle size distribution.

Catani M, Ismail OH, Cavazzini A, Ciogli A, Villani C, Pasti L, Bergantin C, Cabooter D, Desmet G, Gasparrini F, Bell DS.

J Chromatogr A. 2016 Jul 8;1454:78-85. doi: 10.1016/j.chroma.2016.05.037. Epub 2016 May 12.

PMID:
27268519
37.

Experimental evidence of the kinetic performance achievable with columns packed with new 1.9μm fully porous particles of narrow particle size distribution.

Ismail OH, Catani M, Pasti L, Cavazzini A, Ciogli A, Villani C, Kotoni D, Gasparrini F, Bell DS.

J Chromatogr A. 2016 Jul 8;1454:86-92. doi: 10.1016/j.chroma.2016.05.038. Epub 2016 May 12.

PMID:
27234846
38.

Potential benefit of electronic pharmacy claims data to prevent medication history errors and resultant inpatient order errors.

Pevnick JM, Palmer KA, Shane R, Wu CN, Bell DS, Diaz F, Cook-Wiens G, Jackevicius CA.

J Am Med Inform Assoc. 2016 Sep;23(5):942-50. doi: 10.1093/jamia/ocv171. Epub 2016 Jan 17.

39.

Improved Chiral Separation of Methamphetamine Enantiomers Using CSP-LC-MS-MS.

Ward LF, Enders JR, Bell DS, Cramer HM, Wallace FN, McIntire GL.

J Anal Toxicol. 2016 May;40(4):255-63. doi: 10.1093/jat/bkw005. Epub 2016 Feb 10.

PMID:
26869715
40.

Ultra-fast high-efficiency enantioseparations by means of a teicoplanin-based chiral stationary phase made on sub-2 μm totally porous silica particles of narrow size distribution.

Ismail OH, Ciogli A, Villani C, De Martino M, Pierini M, Cavazzini A, Bell DS, Gasparrini F.

J Chromatogr A. 2016 Jan 4;1427:55-68. doi: 10.1016/j.chroma.2015.11.071. Epub 2015 Dec 2.

PMID:
26687167
41.

Aspirin in the prevention of cardiovascular events in patients with diabetes.

Bell DS.

Postgrad Med. 2016;128(2):180-90. doi: 10.1080/00325481.2016.1131106. Epub 2016 Jan 12.

PMID:
26653848
42.

High efficiency, narrow particle size distribution, sub-2 μm based macrocyclic glycopeptide chiral stationary phases in HPLC and SFC.

Barhate CL, Wahab MF, Breitbach ZS, Bell DS, Armstrong DW.

Anal Chim Acta. 2015 Oct 22;898:128-37. doi: 10.1016/j.aca.2015.09.048. Epub 2015 Oct 9.

PMID:
26526918
43.

Changes seen in gut bacteria content and distribution with obesity: causation or association?

Bell DS.

Postgrad Med. 2015;127(8):863-8. doi: 10.1080/00325481.2015.1098519. Epub 2015 Oct 16. Review.

PMID:
26474235
44.
45.

Type 2 diabetes.

Bell DS.

Ann Intern Med. 2015 Aug 18;163(4):322. doi: 10.7326/L15-5122. No abstract available.

PMID:
26280421
46.

Prevention of recurrent nephrolithiasis in adults.

Bell DS.

Ann Intern Med. 2015 Apr 7;162(7):528. doi: 10.7326/L15-5074. No abstract available.

PMID:
25845007
47.

β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature.

DiNicolantonio JJ, Fares H, Niazi AK, Chatterjee S, D'Ascenzo F, Cerrato E, Biondi-Zoccai G, Lavie CJ, Bell DS, O'Keefe JH.

Open Heart. 2015 Mar 21;2(1):e000230. doi: 10.1136/openhrt-2014-000230. eCollection 2015. Review.

48.

Case Reports That Illustrate the Efficacy of SGLT2 Inhibitors in the Type 1 Diabetic Patient.

Bell DS.

Case Rep Endocrinol. 2015;2015:676191. doi: 10.1155/2015/676191. Epub 2015 Feb 16.

49.

Reply: To PMID 22703861.

Albadarin F, Bell DS, O'Keefe JH.

Am J Cardiol. 2015 Mar 15;115(6):852-3. doi: 10.1016/j.amjcard.2014.11.017. Epub 2014 Dec 5. No abstract available.

PMID:
25728847
50.

Effectiveness of a smartphone application for weight loss compared with usual care in overweight primary care patients: a randomized, controlled trial.

Laing BY, Mangione CM, Tseng CH, Leng M, Vaisberg E, Mahida M, Bholat M, Glazier E, Morisky DE, Bell DS.

Ann Intern Med. 2014 Nov 18;161(10 Suppl):S5-12. doi: 10.7326/M13-3005.

Supplemental Content

Support Center